Newsroom
Irish Diagnostics Firm Altratech Aims to Enter Molecular, POC Testing Space by Supplanting PCR
Originally published on 360DX.com by Greg Cima, Mar23, 2023. By Greg Cima NEW YORK – Backed by a mix of governmental contracts and VC funding, Irish startup Altratech is laying out a bold vision that its home-use microfluidic tests could Read More
Meet us at our Tri-Con San Diego booth 305 on Mar 6-8, and hear CEO Tara Dalton present our technology at the home-diagnostics session
Hear from our CEO Tara Dalton as she presents our technology in the home diagnostics session on Tuesday 7th of March.Title of session: 'At-Home Next-Generation Molecular Detection with All-Synthetic PNA and CMOS'
EIC Accelerator grant & equity: Altratech
1 August 2024: . Altratech invited for grant + equity support by EIC's 2024 Accelerator program: Read full article - EIC's 2024 Accelerator program. (Submission preparation assisted by MyEUConsulting SPRL).
Altratech contracted by BARDA for novel PNA Saliva SARS-CoV-2 project
This project has been funded in whole or in part with Federal funds from the US Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority, under Contract No. 75A50122C00067
